Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Mohit K Turagam Added: 1 year ago
AF Symposium 2024 – In this interview, investigator Dr Mohit K Turagam (Icahn School of Medicine at Mount Sinai, US) discusses the findings of a sub-study of the MANIFEST-PF registry.The study investigated the impact of left atrial posterior wall ablation during pulsed field ablation (PFA) for persistent atrial fibrillation.Questions1. What is the MANIFEST-PF registry?2. What is the importance of… View more
Author(s): Isabel Deisenhofer Added: 1 year ago
HRS 2024 — Prof Isabel Deisenhofer (German Heart Center Munich, Technical University of Munich, DE), investigator, joins us to discuss the findings from the TAILORED-AF trial (NCT04702451, Volta Medical).This randomised controlled trial compared a tailored ablation strategy targeting areas of patio-temporal dispersion in combination with pulmonary vein isolation (PVI) to anatomical ablation… View more
Author(s): Andrew Goldsweig Added: 3 months ago
What are the main management recommendations from SCAI and HRS concerning left atrial appendage occlusion?In this short interview, Dr Andrew Goldsweig (Baystate Medical Center, Springfield, US) discusses the new guidelines regarding transcatheter left atrial appendage occlusion by the Society for Cardiovascular Angiography & Interventions and Heart Rhythm Society. The multidisciplinary guideline… View more
Author(s): Alan Bulava Added: 2 years ago
ESC 2023 — Dr Alan Bulava (Ceske Budejovice Hospital and University of South Bohemia, CZ) joins us in this succinct interview to discuss the findings from the SurHyb trial. The SurHyb study was a prospective, open-label-multicentre randomized trial. The study aimed to evaluate CryoMaze surgery alone, as compared to CryoMaze followed by radiofrequency catheter ablation 3-months post-surgery. … View more